LGT administration significantly increased hepatic TNF-α and decreased IL-10 levels (both P<0.01) (Figure 4A,B) compared with the control group, while compatibility with JQC in the ratios (LGT/JQC from 4/1 to 1/4) all significantly reduced LGT-increased TNF-α and LGT-decreased IL-10 levels (all P<0.01) (Figure 4A,B) in hepatic of S180 tumor-bearing mice. This evidence concerns the gene IL10 and neoplasm.